AdaptHealth Corp. (AHCO) Q3 2026 earnings results
AdaptHealth Corp. (AHCO) reported Q3 2026 results on Nov 3, 2026, 8:10:57 AM ET: GAAP EPS -$1.13 vs. -$0.06 expected (miss by 1665.6%); revenue $745.65M vs. $725.87M expected (beat by 2.7%). Outlook: The company revised its fiscal year 2026 guidance for net revenue to $2.88 billion to $2.90 billion.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$1.13 | -$0.06 | Miss by 1665.6% |
| Revenue | $745.65M | $725.87M | Beat by 2.7% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 3, 2026, 8:10:57 AM ET. Nexqual published them 111 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 10.9% from $672.37M; GAAP diluted EPS was -$1.13 vs. $0.17.
Stock reaction
The results came out before the market opened. AHCO closed at $6.28 on November 3, 2026, up 6.3% from its $5.91 close on November 2, 2026 before the results. Latest: $7.39 as of 11:53 AM ET, +25.1% since the pre-release close.
Questions and answers
Did AdaptHealth Corp. beat earnings expectations?
No. AdaptHealth Corp. reported GAAP EPS of -$1.13 against an average analyst estimate of -$0.06 (miss by 1665.6%), and revenue of $745.65M against $725.87M expected (beat by 2.7%).
What were AdaptHealth Corp.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$1.13 and revenue of $745.65M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 10.9% from $672.37M; GAAP diluted EPS was -$1.13 vs. $0.17.
When did AdaptHealth Corp. report Q3 2026 earnings?
Nov 3, 2026, 8:10:57 AM ET, in an SEC 8-K filing (Item 2.02).
How did AHCO stock react to the earnings?
The results came out before the market opened. AHCO closed at $6.28 on November 3, 2026, up 6.3% from its $5.91 close on November 2, 2026 before the results. Latest: $7.39 as of 11:53 AM ET, +25.1% since the pre-release close.
What did AdaptHealth Corp. say about its outlook?
The company revised its fiscal year 2026 guidance for net revenue to $2.88 billion to $2.90 billion.
More on AHCO
AHCO stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 3, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt